As at December 2024, Regulus Therapeutics had cash of US$76m and no debt. Looking at the last year, the company burnt through US$42m. That means it had a cash runway of around 22 months as of December ...
17h
TipRanks on MSNRegulus Therapeutics Reports Positive Trial Results and FinancialsRegulus Therapeutics Inc ( ($RGLS) ) has released its Q4 earnings. Here is a breakdown of the information Regulus Therapeutics Inc presented to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results